Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 51,009	$ 38,935	$ 30,981
General and administrative	20,153	15,724	11,969
Total operating expenses	71,162	54,659	42,950
Loss from operations	(71,162)	(54,659)	(42,950)
Interest income	4,108	188	1,208
Interest expense	(1,185)	(159)	0
Net loss	$ (68,239)	$ (54,630)	$ (41,742)
Net loss per common share, Basic	$ (1.01)	$ (1.04)	$ (0.95)
Net loss per common share, Diluted	$ (1.01)	$ (1.04)	$ (0.95)
Weighted-average shares used to compute net loss per common share, basic	67,368,935	52,759,335	44,004,190
Weighted-average shares used to compute net loss per common share, diluted	67,368,935	52,759,335	44,004,190